CHME vs ABBV: Which Stock is Better?
Side-by-side comparison of China Medicine Corporation and Abbvie Inc in 2026
CHME
China Medicine Corporation
$0.02
ABBV
Abbvie Inc
$215.40
Key Metrics Comparison
| Metric | CHME | ABBV | Winner |
|---|---|---|---|
| Market Cap | $0.47M | $376.20B | ABBV |
| P/E Ratio | N/A | 104.38 | ABBV |
| EPS (TTM) | $N/A | $2.04 | ABBV |
| Revenue Growth | -0.1% | 0.1% | ABBV |
| Gross Margin | 33.5% | 72.0% | ABBV |
Analyze CHME
Full quant analysis
Analyze ABBV
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CHME or ABBV a better investment?
Comparing CHME and ABBV: China Medicine Corporation has a market cap of $0.47M while Abbvie Inc has $376.20B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CHME and ABBV?
CHME (China Medicine Corporation) and ABBV (Abbvie Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CHME or ABBV?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CHME or ABBV?
ABBV has higher revenue growth at 0.1% vs -0.1% for CHME.
Which company is more profitable: CHME or ABBV?
Abbvie Inc (ABBV) has higher gross margins at 72.0% compared to 33.5% for CHME.
Which is the larger company: CHME or ABBV?
Abbvie Inc (ABBV) is larger with a market cap of $376.20B compared to $0.47M for CHME.
Should I buy CHME or ABBV in 2026?
Both CHME and ABBV have investment merit. CHME trades at $0.02 while ABBV trades at $215.40. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CHME and ABBV stock?
Key differences: Market Cap ($0.47M vs $376.20B), P/E Ratio (N/A vs 104.4x), Revenue Growth (-0.1% vs 0.1%), Gross Margin (33.5% vs 72.0%).